Published in
Springer Verlag, Pediatric Drugs, 5(23), p. 515-527, 2021
DOI: 10.1007/s40272-021-00459-x
Links
Tools
Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial
Journal article published in 2021 by
Amy S. Paller,
Andreas Wollenberg,
Elaine Siegfried,
Diamant Thaçi,
Michael J. Cork,
Peter D. Arkwright,
Melinda Gooderham,
Xian Sun,
John T. O’Malley,
Faisal A. Khokhar,
Jignesh Vakil,
Ashish Bansal,
Karli Rosner,
Brad Shumel,
Noah A. Levit 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 